Aehr is betting on silicon photonics to drive sustained growth, as customer ramp ups and new orders are expected to support 15-20% of fiscal 2027 revenues.

AEHR's $22M AI order underscores rising WLBI demand as chip complexity and costs increase, while backlog and bookings point to strong growth.

Hyperscalers' $720B-$745B AI Capex plans are likely to fuel demand for Micron, FormFactor, Texas Instruments and NVIDIA across the chip supply chain.

FormFactor (FORM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

ASX surges 82% in six months as strong AI packaging demand, rising LEAP sales and expanding margins support its growth outlook.

FormFactor (FORM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

FORM, LRCX, VRT, MBIN and SNDR have been added to the Zacks Rank #1 (Strong Buy) List on August 3rd, 2026.

VSH heads into Q2 earnings with stronger demand, pricing support and AI growth, but rising costs, heavy spending and a rich valuation favor a hold.

Aehr's record bookings, AI-driven backlog and expanding burn-in portfolio give it the edge over FormFactor for long-term growth.

FORM's Q2 earnings beat estimates as record revenues, HBM strength and a systems rebound support an upbeat third-quarter outlook.